IL141990A0 - Antigen presenting cells with genetically enhanced cytokine expression - Google Patents

Antigen presenting cells with genetically enhanced cytokine expression

Info

Publication number
IL141990A0
IL141990A0 IL14199099A IL14199099A IL141990A0 IL 141990 A0 IL141990 A0 IL 141990A0 IL 14199099 A IL14199099 A IL 14199099A IL 14199099 A IL14199099 A IL 14199099A IL 141990 A0 IL141990 A0 IL 141990A0
Authority
IL
Israel
Prior art keywords
presenting cells
antigen presenting
cytokine expression
enhanced cytokine
genetically enhanced
Prior art date
Application number
IL14199099A
Other languages
English (en)
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Publication of IL141990A0 publication Critical patent/IL141990A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/208IL-12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/461Cellular immunotherapy characterised by the cell type used
    • A61K39/4615Dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/462Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622Antigen presenting cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/464Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643Vertebrate antigens
    • A61K39/4644Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5154Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5156Animal cells expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL14199099A 1998-09-15 1999-09-14 Antigen presenting cells with genetically enhanced cytokine expression IL141990A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10046898P 1998-09-15 1998-09-15
PCT/US1999/021097 WO2000015264A1 (en) 1998-09-15 1999-09-14 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression

Publications (1)

Publication Number Publication Date
IL141990A0 true IL141990A0 (en) 2002-03-10

Family

ID=22279913

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14199099A IL141990A0 (en) 1998-09-15 1999-09-14 Antigen presenting cells with genetically enhanced cytokine expression
IL141990A IL141990A (en) 1998-09-15 2001-03-13 Antigen-presenting cells with genetically enhanced cytokine expression

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141990A IL141990A (en) 1998-09-15 2001-03-13 Antigen-presenting cells with genetically enhanced cytokine expression

Country Status (8)

Country Link
US (2) US6482405B1 (zh)
EP (1) EP1113821A1 (zh)
JP (2) JP4768916B2 (zh)
CN (1) CN1330557A (zh)
AU (1) AU6144499A (zh)
CA (1) CA2343355A1 (zh)
IL (2) IL141990A0 (zh)
WO (1) WO2000015264A1 (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7402307B2 (en) 1998-03-31 2008-07-22 Geron Corporation Method for identifying and killing cancer cells
CA2347067C (en) 1998-03-31 2013-09-17 Geron Corporation Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
JP4768916B2 (ja) * 1998-09-15 2011-09-07 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション サイトカイン発現が遺伝的に増強された抗原提示細胞のインサイチュ注入
DE10024383B4 (de) * 2000-05-17 2005-07-21 Mack, Gerd R. Mit toxischen Substanzen beladene dendritische Zellen
CA2746308A1 (en) * 2001-12-17 2003-06-26 Zymogenetics, Inc. Method for treating human papilloma virus
JP2005529113A (ja) * 2002-04-10 2005-09-29 ザイモジェネティクス,インコーポレイティド 子宮頚癌を治療するためのインターロイキン−19の使用法
AU2003235948A1 (en) * 2002-04-25 2003-11-10 Chugai Seiyaku Kabushiki Kaisha Remedy for lung cancer
US20040057935A1 (en) * 2002-09-20 2004-03-25 Cedars-Sinai Medical Center Intratumoral delivery of dendritic cells
WO2004034995A2 (en) * 2002-10-15 2004-04-29 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods and reagents for inducing immunity
BRPI0317064B8 (pt) * 2002-12-06 2021-05-25 Northwest Biotherapeutics Inc composições compreendendo células dendríticas parcialmente amadurecidas in vitro
SE0301109D0 (sv) * 2003-04-14 2003-04-14 Mallen Huang Nucleotide vaccine composition
US20050002904A1 (en) * 2003-07-03 2005-01-06 Wary Kishore K. Uses of vascular endothelial growth factor and type I collagen inducible protein (VCIP)
JP2007507543A (ja) * 2003-10-06 2007-03-29 セダーズ−シナイ メディカル センター 樹状細胞治療によって誘導されるt細胞アネルギーを予防するためのcox−2インヒビターの使用
EP1676132B1 (en) * 2003-10-21 2014-01-22 Cedars-Sinai Medical Center Combination of chemotherapy and administration of glioma-antigen-pulsed dendritic cells in the treatment of glioma
US20050214268A1 (en) * 2004-03-25 2005-09-29 Cavanagh William A Iii Methods for treating tumors and cancerous tissues
US8076132B2 (en) 2004-09-17 2011-12-13 Hasumi International Research Foundation Dendritic cell tumor injection (DCTI) therapy
US20060216269A1 (en) * 2004-09-17 2006-09-28 Kenichiro Hasumi Dendritic cell tumor injection (DCTI) therapy
WO2008039874A2 (en) * 2006-09-26 2008-04-03 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
WO2008039969A2 (en) 2006-09-28 2008-04-03 Cedars-Sinai Medical Center Cancer vaccines and vaccination methods
EP2205249B1 (en) 2007-09-28 2018-11-07 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
ES2531522T3 (es) * 2007-10-08 2015-03-16 Intrexon Corporation Células dendríticas modificadas por ingeniería y usos para el tratamiento del cáncer
EP2328923B1 (en) * 2008-09-02 2016-01-13 Cedars-Sinai Medical Center Cd133 epitopes
WO2010042189A2 (en) 2008-10-08 2010-04-15 Intrexon Corporation Engineered cells expressing multiple immunomodulators and uses thereof
WO2010129895A2 (en) * 2009-05-07 2010-11-11 Immunocellular Therapeutics, Ltd. Cd133 epitopes
WO2014007667A1 (ru) * 2012-06-25 2014-01-09 Volgushev Sergei Anatolievich Аутологичная вакцина для лечения туберкулеза легких и способ ее получения
WO2014007669A1 (ru) * 2012-07-04 2014-01-09 Volgushev Sergei Anatolievich Аутологичная клеточная вакцина для лечения онкологических заболеваний и способ ее получения
WO2014127296A1 (en) 2013-02-14 2014-08-21 Immunocellular Therapeutics, Ltd Cancer vaccines and vaccination methods
JP2018537432A (ja) 2015-11-09 2018-12-20 イミューン デザイン コーポレイション Il−12を発現するレンチウイルスベクターを含む組成物およびその使用法
WO2021034943A1 (en) * 2019-08-19 2021-02-25 Wayne State University In vivo immunoimaging of interleukin-12

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2531418A (en) * 1947-05-13 1950-11-28 Fitzharris Edward Jet casting arrow
US3703783A (en) * 1971-06-03 1972-11-28 Samuel T Pool Trot line caster
US4484405A (en) * 1980-05-30 1984-11-27 Woods Milton D Free floating fishing rig
US4831762A (en) * 1988-03-31 1989-05-23 Harris Olin P Fishing float
US5681562A (en) 1991-06-25 1997-10-28 Sidney Kimmel Cancer Center Lymphokine gene therapy of cancer
US5674486A (en) 1991-06-25 1997-10-07 San Diego Regional Cancer Center Cancer immunotherapy with carrier cells
KR960701988A (ko) 1993-04-20 1996-03-28 윌리엄 에스. 로빈슨 세포내 감염원에 감염된 개체의 치료방법 및 치료물질(methods and materials for treatment of individuals infected with intracellular in-fectious agents)
US5962318A (en) * 1996-11-15 1999-10-05 St. Jude Children's Research Hospital Cytotoxic T lymphocyte-mediated immunotherapy
AU1710699A (en) * 1997-12-18 1999-07-05 G.D. Searle & Co. Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity
JP4768916B2 (ja) * 1998-09-15 2011-09-07 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション サイトカイン発現が遺伝的に増強された抗原提示細胞のインサイチュ注入
US20010032408A1 (en) * 1999-12-09 2001-10-25 Presnell Bobby B. Triangular fishing float

Also Published As

Publication number Publication date
IL141990A (en) 2007-07-24
JP4768916B2 (ja) 2011-09-07
US20030060442A1 (en) 2003-03-27
CN1330557A (zh) 2002-01-09
JP2010260869A (ja) 2010-11-18
WO2000015264A9 (en) 2000-12-14
CA2343355A1 (en) 2000-03-23
EP1113821A1 (en) 2001-07-11
WO2000015264A1 (en) 2000-03-23
AU6144499A (en) 2000-04-03
US6482405B1 (en) 2002-11-19
JP2002524537A (ja) 2002-08-06

Similar Documents

Publication Publication Date Title
IL141990A0 (en) Antigen presenting cells with genetically enhanced cytokine expression
IL205765A0 (en) Mammalian cytokine: interleukin - b - 30 and isolated polunucleotides encoding the same
EP1055757A4 (en) THREE-DIMENSIONAL STRUCTURE NET, AND COMPOSITE STRUCTURAL MATERIAL USING SAID NET
EP1011387A4 (en) CHAIR AND BACKPACK COMBINATION
GB9819260D0 (en) Solar cell arrangements
HK1045763B (zh) 燃料電池組件及供燃料電池組件使用的方法
AU8777898A (en) Methods for genetically modifying t cells
AU3491195A (en) Genetically engineered cells that produce dopamine
GB9924963D0 (en) Chair with standing aid
AU3243595A (en) Genetically engineered swine cells
AU3669899A (en) Field emitter cell and array with vertical thin-film-edge emitter
GB9723987D0 (en) Solar collector with auto-vent
GB9605453D0 (en) Cultured cells
EP1165124A4 (en) RECOMBINANT NEOSPORA ANTIGENS AND USES THEREOF
HU9700218V0 (en) Soft drink-can with straw
GB2324334B (en) Mail collector
AU3474595A (en) Genetically altered t-cells
IT1291430B1 (it) Procedimento per realizzare formelle in legno lamellare lavorato superficialmente e formella realizzata col procedimento
DE29723168U1 (de) Umschlag mit Schutzeinlage
GB2323275B (en) Improvements in chairs
GB2334437A8 (en) Chair with alternative back rests
GB9721786D0 (en) Protein associated with cells possessing an altered phenotype
GB9923764D0 (en) Protein associated with cells possessing an altered phenotype
GB9821804D0 (en) Protein associated with cells possessing an altered phenotype
TW380399U (en) Chair with back

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed